The Miami Entrepreneur

Dow Jones Newswires: GlaxoSmithKline to buy Sierra Oncology for $1.9 billion

Read Time:7 Second

Pharmaceutical giant GlaxoSmithKline PLC said Wednesday that it is buying biopharmaceutical company Sierra Oncology Inc. for $1.9 billion, and backed its guidance.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Dow Jones Newswires: Tesco profit jumps as revenue rises faster than forecast
Next post Dow Jones Newswires: New Zealand central bank accelerates monetary tightening with rate hike